41

Center Laboratories

4123 · TWO · Healthcare / Drug Manufacturers - Specialty & Generic

28.90TWD+0.60 (+2.12%)

Price History

Full chart

Market Stats

Previous Close28.30
Open28.40
Day Range28.35 – 29.10
52-Week Range29.35 – 46.34
Volume978.92K
Market Cap23.35B
P/E (TTM)78.00
Forward P/E2500.00
EPS0.40
Dividend Yield5.60%
Beta0.27
50-Day Avg32.62
200-Day Avg36.83

About

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretic analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also provides central nervous system medication consisting of treatments for cerebrovascular disease, dementia, depression, schizophrenia, epilepsy, and Parkinson's disease. Center Laboratories, Inc. was founded in 1959 and is headquartered in Taipei, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Su-Chi Wang
  • Employees0
  • HeadquartersNo. 3-2, Building H, Taipei, Taiwan, 115, Taiwan
  • Websitehttps://www.centerlab.com.tw

Leadership

  • Ms. Su-Chi WangCEO, Chief Investment Officer, COO & Chairman
  • An-Ni MaoManager of Finance & Accounting Department
  • Ms. Hsiu Yueh LinDirector of Administration Department
  • Ms. Min-Li LienAssistant Vice President of Legal Affairs Department
  • Ms. Ching-Yu TangHead of Corporate Governance
  • Mr. Jui-Pao HsuManager
  • Ms. Chiun-Yu LinPlant Director

Financials

Income Statement

Currency: TWD2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue253.58M299.71M364.52M462.22M569.03M684.44M713.74M741.93M898.76M6.79B15.04B19.39B21.65B1.44B717.04M500.11M767.72M1.39B1.62B1.52B
Growth (%)-+18.19%+21.62%+26.80%+23.11%+20.28%+4.28%+3.95%+21.14%+655.74%+121.43%+28.94%+11.64%-93.36%-50.12%-30.25%+53.51%+81.58%+16.06%-6.28%
Cost of Revenue126.28M154.44M199.87M261.41M331.72M414.23M424.30M466.03M538.78M4.38B8.79B10.94B11.32B817.95M366.75M240.45M361.45M775.91M868.92M894.93M
Gross Profit127.30M145.27M164.65M200.81M237.31M270.21M289.44M275.90M359.98M2.41B6.25B8.45B10.33B619.72M350.30M259.66M406.27M618.09M748.95M621.26M
Gross Margin50.20%48.47%45.17%43.44%41.70%39.48%40.55%37.19%40.05%35.52%41.57%43.58%47.72%43.11%48.85%51.92%52.92%44.34%46.29%40.97%
Operating Expense93.31M100.42M132.39M197.18M259.65M265.80M330.05M315.76M429.49M2.46B5.82B7.56B9.04B741.49M58.33M-785.00M274.33M697.36M514.63M983.34M
Operating Income33.99M44.85M32.27M3.63M-22.33M4.41M-40.61M-39.85M-69.51M-46.69M429.63M888.04M1.29B-121.76M291.97M1.04B131.94M-79.27M234.32M-362.08M
Operating Margin13.40%14.97%8.85%0.79%-3.92%0.64%-5.69%-5.37%-7.73%-0.69%2.86%4.58%5.95%-8.47%40.72%208.89%17.19%-5.69%14.48%-23.88%
EBITDA52.22M74.39M82.22M44.70M28.27M38.12M-41.16M158.97M647.41M984.55M1.59B2.54B2.46B-2.99M349.11M1.08B164.96M-175.17M-781.43M11.95B
EBITDA Margin20.59%24.82%22.55%9.67%4.97%5.57%-5.77%21.43%72.03%14.50%10.60%13.11%11.34%-0.21%48.69%215.80%21.49%-12.57%-48.30%787.92%
Net Income15.34M114.65M45.46M138.41M12.96M42.56M99.85M51.91M333.26M421.50M19.45M250.00M6.08B-203.59M3.79B1.82B-575.62M-1.05B-1.10B9.32B
Net Income Margin6.05%38.25%12.47%29.94%2.28%6.22%13.99%7.00%37.08%6.21%0.13%1.29%28.10%-14.16%528.07%363.16%-74.98%-75.15%-68.22%614.89%
R&D------141.53M129.39M147.61M124.01M518.01M805.59M732.41M206.33M128.87M75.40M47.02M82.76M71.96M84.78M
R&D as % of Total Revenue------19.83%17.44%16.42%1.83%3.44%4.15%3.38%14.35%17.97%15.08%6.12%5.94%4.45%5.59%
Interest Expense5.47M3.26M8.80M9.96M3.90M3.14M4.41M1.64M6.97M192.82M192.40M197.69M223.77M107.04M83.34M102.75M82.69M200.18M227.53M204.36M
Interest Expense % of Total Revenue2.16%1.09%2.41%2.15%0.69%0.46%0.62%0.22%0.78%2.84%1.28%1.02%1.03%7.45%11.62%20.55%10.77%14.36%14.06%13.48%

Balance Sheet

Currency: TWD2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets495.58M648.84M1.02B2.42B2.45B2.61B4.08B5.46B9.62B27.91B30.35B38.30B20.38B22.87B27.87B30.44B25.19B27.00B25.54B34.63B
Total Liabilities222.51M177.67M443.09M302.16M268.74M398.01M607.42M451.94M2.68B13.03B14.53B21.43B4.91B7.41B7.23B9.35B5.94B6.79B7.48B8.14B
Total Equity273.07M471.17M530.13M1.58B1.66B1.65B2.35B3.69B5.26B6.59B6.79B6.80B13.07B13.27B17.98B18.94B19.25B19.76B18.05B26.49B
Cash65.14M49.11M303.42M1.53B1.10B589.80M461.36M628.33M1.14B3.52B3.97B4.49B1.48B666.11M923.38M267.46M796.74M1.70B1.44B237.56M
Total Debt133.68M67.16M310.57M93.91M40.92M236.09M126.50M47.84M2.23B8.80B8.87B12.38B2.86B4.37B3.77B5.27B3.47B5.62B--
Net Debt68.54M18.05M7.15M-1.44B-1.06B-353.72M-334.86M-580.49M1.09B5.28B4.90B7.89B1.39B3.71B2.84B5.00B2.68B3.92B5.07B4.46B

Cash Flow

Currency: TWD2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow38.81M67.71M44.86M39.11M-3.86M70.11M16.23M41.50M-7.54M-138.29M1.16B2.01B617.84M-286.45M-269.56M-358.14M-189.88M-963.44M394.74M27.16M
Investing Cash Flow------------4.27B-1.99B-2.68B305.67M-655.88M----
Financing Cash Flow-61.45M13.19M305.69M1.09B-78.83M173.72M149.03M896.87M3.45B4.76B1.58B2.39B-1.31B2.17B224.94M358.10M-4.46B2.00B--
Capital Expenditure2.17M43.55M133.97M61.61M45.03M246.59M145.49M122.94M94.43M440.36M1.66B2.99B1.66B622.13M72.83M6.65M7.55M157.16M178.49M208.21M
Free Cash Flow36.64M24.16M-89.11M-22.49M-48.89M-176.47M-129.26M-81.43M-101.97M-578.65M-502.75M-977.32M-1.04B-908.58M-342.40M-364.79M-197.43M-1.12B216.24M-181.05M
Dividends Paid----------117.63M177.71M1.50B525.42M623.67M1.05B1.75B589.92M1.03B540.27M
FCF to OCF94.40%35.69%-198.67%-57.51%1266.17%-251.70%-796.44%-196.20%1352.54%418.43%-43.50%-48.53%-168.55%317.18%127.02%101.86%103.98%116.31%54.78%-666.51%
Dividend Paid to FCF-----------23.40%-18.18%-144.37%-57.83%-182.15%-288.46%-886.27%-52.64%476.61%-298.41%

Earnings

Report DateMar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Apr 28, 2009Sep 2, 2009Oct 30, 2009Mar 3, 2010Jun 2, 2010Sep 1, 2010Oct 15, 2010Mar 2, 2011Apr 24, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 13, 2013Feb 26, 2014May 14, 2014Aug 14, 2014Nov 14, 2014Feb 25, 2015May 15, 2015Aug 14, 2015Nov 16, 2015Mar 2, 2016May 24, 2016Aug 16, 2016Nov 14, 2016Mar 1, 2017Apr 3, 2017Aug 14, 2017Nov 14, 2017Mar 31, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Feb 27, 2019Apr 2, 2019Aug 28, 2019Nov 27, 2019Feb 26, 2020Jun 3, 2020Sep 2, 2020Dec 2, 2020Mar 3, 2021May 17, 2021Aug 12, 2021Nov 11, 2021Mar 22, 2022May 12, 2022Aug 16, 2022Nov 11, 2022Mar 15, 2023May 12, 2023
EPS Estimate----0.06-0.16---0.02-0.09----------0.07-0.020.010.10--0.15-0.19-----------0.970.911.291.42----------------
EPS Actual0.17-0.290.280.060.050.210.240.020.010.020.010.000.010.010.020.030.00-0.060.030.34-0.01-0.080.130.090.040.27-0.260.82-0.14-0.20-0.021.26-0.12-0.110.40-0.15-0.04-0.040.100.480.810.282.796.256.870.070.06-0.250.382.201.632.324.432.56-1.61-1.402.58-0.31-1.840.031.60
Surprise-----16.67%-50.00%----50.00%--88.89%---------285.71%-100.00%2600.00%-360.00%-6.67%-5.26%------------71.13%206.59%384.50%383.80%----------------
Timing----After-hours-Pre-market---After-hours-After-hours---------Pre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-market----------Pre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap23.35B
Enterprise Value23.83B
Trailing P/E78.00
Forward P/E2500.00
Price / Sales14.10
Price / Book1.37
EPS0.40
Book Value21.69
Revenue (TTM)1.66B
Gross Profit (TTM)716.93M
EBITDA222.57M
Profit Margin61.51%
Operating Margin112.46%
Return on Equity6.00%
Return on Assets0.15%
Shares Outstanding748.50M
Shares Float591.07M
Beta0.27
Dividend Yield5.60%
Dividend Rate1.75
Payout Ratio179.58%

Dividends

20261×
1.75Aug 17, 2026
20251×
0.72Oct 3, 2025
20241×
1.30Aug 2, 2024
20231×
0.90Sep 8, 2023
20221×
2.00Sep 8, 2022
20211×
1.07Sep 13, 2021
20201×
0.93Aug 6, 2020
20191×
0.93Aug 16, 2019
20181×
1.31Aug 9, 2018

Stock Splits

  • Aug 17, 20261049.9055:1000
  • Oct 3, 20251050.6929:1000
  • Sep 8, 20231101602.2:1000000
  • Sep 8, 20221145.9683:1000
  • Sep 13, 20211099.717:1000
  • Aug 6, 20201047.554:1000
  • Aug 16, 20191149.94:1000
  • Aug 9, 20181048.287:1000
  • Sep 7, 20171100:1000
  • Sep 7, 20161095.412:1000
  • Sep 7, 20151100:1000
  • Aug 11, 20141150:1000
  • Sep 27, 20131.043:1
  • Aug 17, 20121.0486:1
  • Aug 18, 20111.125:1
  • Aug 12, 20101250:1000
  • Aug 14, 2009117.55:100
  • Aug 21, 2008120:100